以下文章来源于CVC50 ，作者mira CVC50 . 聚焦CVC未来趋势，通过研究、会议、社群，推动CVC行业发展。 导读： 8月份， 上市公司出资持续活跃。 作者丨Mira 据FOFWEEKLY统计，上交所、深交所共有50家上市公司(含子公司)对私募股权基金进行了出资， 共投向46支基金，出资笔数共计51笔，已披露金额的出资额合计56.84亿元，平均单笔出资额1.11 亿元。 从行业维度看，8月出资的 上市公司医疗保健行业企业出资最多， 其次是工业、信息技术和可选 消费行业上市公司。同时医疗保健出资规模最大，出资主要集中在生物医药和健康科技方向。 在地域分布方面， 浙江省的上市公司出资最为踊跃， 不论在出资家数还是总规模上都占据首位； 广东省位列第二。两地上市公司合计出资规模均突破十亿元，显示出强劲的区域资本活力。 0.00 0 -4月 10月 12月 7月 8月 9月 11月 2月 3月 4月 2月 6月 2024年 2025年 出资规模(亿元) = -出资次数 8月份,上交所、深交所共有50家上市公司(含子公司)对私募股权基金进行了出资,共 投向46支基金,出资笔数共计51笔,已披露金额的出资额合计 ...

Group 1 - The company, Huadong Medicine (000963.SZ), announced its participation as a limited partner in a new investment fund, "Hangzhou Fuguang Hongze Equity Investment Partnership (Limited Partnership)" [1] - The total committed capital for the fund is RMB 2 billion, with the company contributing RMB 980 million, representing a 49% stake [1] - The investment focus of the fund includes innovative pharmaceuticals, medical aesthetics, health and wellness, animal health, and other sectors related to biology, medicine, and health that align with Hangzhou's five major industrial ecosystems [1]

Core Viewpoint - The company has approved the establishment of a joint investment fund aimed at the pharmaceutical industry, with a total commitment of RMB 2 billion, to enhance its competitive edge in innovative sectors [1] Investment Fund Details - The investment fund, named "Hangzhou Fuguang Hongze Equity Investment Partnership (Limited Partnership)," will be co-established with Shanghai Fuguang Private Equity Fund Management Co., Ltd., Hangzhou Industrial Investment Co., Ltd., and Hangzhou Gongshu Industrial Fund Co., Ltd. [1] - The total subscribed capital of the fund is RMB 2 billion, with the company contributing RMB 980 million, representing a 49% stake [1] Investment Focus - The fund will primarily invest in sectors such as innovative pharmaceuticals, medical aesthetics, health and wellness, animal health, and other areas related to biology, medicine, and health that align with Hangzhou's five major industrial ecosystems [1] - The objective of the fund is to reduce the upfront costs associated with identifying and introducing high-quality innovative projects, diversify investment risks, and consolidate resources to strengthen the company's core competencies in key areas like innovative pharmaceuticals, medical aesthetics, and industrial microbiology [1]

Group 1 - The core viewpoint of the news is that Baiyunshan's subsidiary, Guangyao Caizhilin, has received approval for an environmental impact assessment for its production service base project, with a total investment of 59.96 million yuan [1] - The "A-share Green Report" project aims to enhance transparency in environmental information of listed companies, utilizing authoritative environmental regulatory data from 31 provinces and 337 cities [1] - The latest A-share Green Weekly Report indicated that eight listed companies have recently exposed environmental risks [1] Group 2 - Baiyunshan's main business segments include large commerce (69.32% of revenue), health (16.79%), traditional Chinese medicine (12.53%), and other businesses [2] - In the first half of 2025, Baiyunshan reported a revenue of 41.835 billion yuan, with a net profit attributable to shareholders of 2.516 billion yuan [3] - The company's gross profit margin for the first half of 2025 was 18.32%, with a return on equity of 6.83% [3]

Core Viewpoint - The Ministry of Commerce has announced the first batch of 38 pilot cities for retail innovation and enhancement, including Shenyang and Dalian, aiming to improve consumer experiences and service quality in these cities [1][2]. Group 1: Pilot Cities and Implementation - Shenyang and Dalian have been selected as pilot cities for the national retail innovation enhancement initiative [1]. - The pilot program will last for two years, with new cities being selected annually from 2025 to 2029, promoting successful cases and experiences [1]. Group 2: Focus Areas for Pilot Cities - Shenyang's focus will be on "one store, one strategy" scenario-based transformation, quality supply, and policy innovation [2]. - Dalian's focus will also include "one store, one strategy" scenario-based transformation, quality supply, and diversified innovation [2]. Group 3: Specific Implementation Strategies - The initiative encourages scenario-based transformation by enhancing operational functions, optimizing environments, and improving service facilities while ensuring safety [2]. - Quality supply will be promoted through initiatives like trade-in programs for traditional consumer goods and fostering new consumption growth points in smart home products and health-related items [2]. - Diversified innovation will include the development of boutique stores, pop-up shops, and brand discount stores, emphasizing unique and specialized retail experiences [2]. Group 4: Support and Facilitation Measures - Pilot cities are required to facilitate project planning, approval processes, land use changes, and financing in accordance with the implementation plan [3]. - The initiative aims to leverage various policies to enhance the business environment and support modern commercial circulation systems [3].